Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart attacks and strokes

Biotech's stock is up 13% in the week to date after Novo Nordisk said its Wegovy obesity treatment reduced the risk of cardio events by 20% in obese adults.